Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3275307
Max Phase: Preclinical
Molecular Formula: C19H25BrN4O6
Molecular Weight: 405.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3275307
Max Phase: Preclinical
Molecular Formula: C19H25BrN4O6
Molecular Weight: 405.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C(=O)NO)C(CO)Cc1c[n+](CC(=O)c2ccc([N+](=O)[O-])cc2)cn1C.[Br-]
Standard InChI: InChI=1S/C19H24N4O6.BrH/c1-3-17(19(26)20-27)14(11-24)8-16-9-22(12-21(16)2)10-18(25)13-4-6-15(7-5-13)23(28)29;/h4-7,9,12,14,17,24H,3,8,10-11H2,1-2H3,(H-,20,26,27);1H
Standard InChI Key: KYMGXZIXGVCOCT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.43 | Molecular Weight (Monoisotopic): 405.1769 | AlogP: 0.79 | #Rotatable Bonds: 10 |
Polar Surface Area: 138.58 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.87 | CX Basic pKa: | CX LogP: -2.90 | CX LogD: -2.91 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.18 | Np Likeness Score: -0.23 |
1. Ben-Bassat AA, Lavie D.. (1976) Quaternary pilocarpine derivatives as potential acetylcholine antagonists. 2. Alterations in the lactone and imidazole moieties., 19 (7): [PMID:940111] [10.1021/jm00229a014] |
Source(1):